Announcements Trials
Browse Landscape

Phase

Phase 2 2Phase EARLY_PHASE1 1

Status

Terminated 5Completed 4Withdrawn 3Recruiting 3Suspended 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Head & Neck 2CNS 2

Conditions

Squamous Cell Carcinoma of Head and Neck 2Brain Neoplasms 2

Interventions

Specimen Handling 334Magnetic Resonance Spectroscopy 334Radiotherapy 315Cyclophosphamide 295pembrolizumab 281Cisplatin 267Carboplatin 245Drug Therapy 237Blood Specimen Collection 233Biopsy 204Bevacizumab 186Gemcitabine 178venetoclax 172Radiosurgery 169Capecitabine 164Oxaliplatin 163fludarabine 161Nivolumab 156Paclitaxel 155Standard of Care 136Surveys and Questionnaires 130Surgical Procedures, Operative 130Dexamethasone 126Fluorouracil 124Docetaxel 113tislelizumab 110Rituximab 110Cytarabine 104Azacitidine 101atezolizumab 100

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Recruiting × OTHER × fluoromisonidazole × Clear all
NCT03649880 2025-03-25

Feasibility of FMISO in Brain Tumors

OHSU Knight Cancer Institute

Phase 2 Recruiting
50 enrolled
CNS

Brain Neoplasms

NCT06087614 2025-01-17

DE-HyART

Rajiv Gandhi Cancer Institute & Research Center, India

Phase 2 Recruiting
124 enrolled
Head & Neck

Squamous Cell Carcinoma of Head and Neck

NCT05996432 2024-09-23

Image-Based, In-Vivo Assessment of Tumor Hypoxia to Guide Hypoxia-Driven Adaptive Radiation Therapy

Vanderbilt-Ingram Cancer Center

Phase EARLY_PHASE1 Recruiting
48 enrolled
CNSHead & Neck

Squamous Cell Carcinoma of Head and Neck, Brain Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡